Additionally, in peritoneal LAMs, the expression of CD206, CXCL9 and iNOS initially increases and subsequently decreases as the tumor progresses, whereas the expression of IL-1β and IL-6 first decreases and then increases. Here, MRC1 is linked to neoplasm.